| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/17/2000 | WO1999058675A3 Human genes and gene expression products v |
| 02/17/2000 | WO1999057289A3 INHIBIN-HBc FUSION PROTEIN |
| 02/17/2000 | WO1999057241A9 Myelin basic protein peptides and uses thereof |
| 02/17/2000 | WO1999056784A3 Inprovements in gene therapy using compositions comprising a polynucleotide and a nuclease inhibitor or interleukin-10 |
| 02/17/2000 | WO1999056763A9 Use of neglected target tissue antigens in modulation of immune responses |
| 02/17/2000 | WO1999055859A3 Cd40-interacting and traf-interacting proteins |
| 02/17/2000 | WO1999054466A3 Colon cancer-associated antigens and their diagnostic and therapeutic uses |
| 02/17/2000 | WO1999051779A9 Glaucoma therapeutics and diagnostics |
| 02/17/2000 | WO1999051756A9 Promoter and constructions for expression of recombinant proteins in filamentous fungi |
| 02/17/2000 | WO1999050461A9 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis |
| 02/17/2000 | WO1999047923A9 Assays for screening compounds which interact with cation channel proteins, mutant prokaryotic cation channel proteins, and uses thereof |
| 02/17/2000 | WO1999046371A9 Induction of apoptotic or cytotoxic gene expression by adenoviral mediated gene codelivery |
| 02/17/2000 | WO1999045955A9 DIAGNOSIS, PREVENTION AND TREATMENT OF ULCERATIVE COLITIS, AND CLINICAL SUBTYPES THEREOF, USING MICROBIAL UC pANCA ANTIGENS |
| 02/17/2000 | WO1999020261A3 Use of antigunal agents for the topial treatment of fungus-induced mucositis |
| 02/17/2000 | WO1998029442A9 ANNEXIN V-BINDING POLYPEPTIDES DERIVED FROM HBsAg AND THEIR USES |
| 02/17/2000 | DE19836615A1 Preparation of antibody composition useful for purifying components of biological fluids comprises immunizing animals with native and denatured protein fractions |
| 02/17/2000 | DE19834909A1 Faserproteine und ihre Herstellung Fibrous proteins and their preparation |
| 02/17/2000 | CA2672025A1 Genes involved in tolerance to environmental stress |
| 02/17/2000 | CA2362013A1 Transgenic plant expressing soybean glycinin |
| 02/17/2000 | CA2348151A1 A novel method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 02/17/2000 | CA2347656A1 A novel method of diagnosing, monitoring, staging, imaging and treating lung cancer |
| 02/17/2000 | CA2339891A1 Chp polypeptide, a ligand of pak65 |
| 02/17/2000 | CA2339876A1 Use of an animal model deficient in p53 and having memory deficiency and/or behavioural disorders for therapeutic purposes |
| 02/17/2000 | CA2339416A1 Short oligonucleotides for the inhibition of vegf expression |
| 02/17/2000 | CA2339347A1 Novel g protein-coupled receptor cdna sequence |
| 02/17/2000 | CA2339322A1 Genes involved in the molecular paths for tumour suppression and /or resistance to viruses |
| 02/17/2000 | CA2339086A1 Dna replication- and repair-associated proteins |
| 02/17/2000 | CA2339083A1 Nucleic sequences coding for an at2 interacting protein interacting with the at2 receptor and their applications |
| 02/17/2000 | CA2338983A1 Prevention and treatment of viral disease |
| 02/17/2000 | CA2338385A1 Human receptor-associated proteins |
| 02/17/2000 | CA2338383A1 Method for selective and optionally reversible degeneration of somatic plant tissue |
| 02/17/2000 | CA2338185A1 Thermostable in vitro complex with polymerase activity |
| 02/17/2000 | CA2338020A1 Trimer of hiv env gene expression product |
| 02/17/2000 | CA2337968A1 Herpesvirus preparations and their uses |
| 02/17/2000 | CA2337964A1 Treatment of central nervous system ischemia or trauma with epidermal growth factor-like polypeptides |
| 02/17/2000 | CA2337904A1 Novel genes in control of hematopoiesis |
| 02/17/2000 | CA2337861A1 A plant disease resistance signalling gene: materials and methods relating thereto |
| 02/17/2000 | CA2337741A1 Pancreatic and ovarian polypeptide, zsig58 |
| 02/17/2000 | CA2337712A1 Molecules designated b7l-1 |
| 02/17/2000 | CA2337693A1 Transgenic animals having a modified glycoprotein v gene |
| 02/17/2000 | CA2337083A1 Anti-apoptotic compositions comprising the r1 subunit of herpes simplex virus ribonucleotide reductase or its n-terminal portion; and uses thereof |
| 02/17/2000 | CA2336523A1 Immunological herpes simplex virus antigens and methods for use thereof |
| 02/17/2000 | CA2336064A1 Fibrous proteins and the production thereof |
| 02/17/2000 | CA2335648A1 A novel g protein-coupled receptor protein and its dna |
| 02/17/2000 | CA2335344A1 Production and use of modified cystatins |
| 02/17/2000 | CA2328494A1 Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis c virus protease |
| 02/16/2000 | EP0979873A1 Gene for petunia transcription factor PetSPL2 and its use |
| 02/16/2000 | EP0979872A1 Animal model for the development and therapy of diabetes mellitus |
| 02/16/2000 | EP0979871A1 NOVEL dlg FAMILY MOLECULE, POLYNUCLEOTIDE ENCODING THE SAME, ANTIBODY AGAINST THE SAME, AND METHOD FOR DETECTING dlg GENE |
| 02/16/2000 | EP0979870A1 Human Wnt-6 polypeptide |
| 02/16/2000 | EP0979869A1 Short oligonucleotides for the inhibition of VEGF expression |
| 02/16/2000 | EP0979867A2 Immunodominant human T-cell epitopes of hepatitis C virus |
| 02/16/2000 | EP0979831A2 Antibacterial peptides and antibacterial agents containing such peptides as an effective ingredient |
| 02/16/2000 | EP0979830A1 A novel class of xylanase inhibitors |
| 02/16/2000 | EP0979298A1 Metastasis models using green fluorescent protein (gfp) as a marker |
| 02/16/2000 | EP0979297A1 A conditional replication and expression system |
| 02/16/2000 | EP0979295A1 Expression of fungicide-binding polypeptides in plants for producing fungicide tolerance |
| 02/16/2000 | EP0979293A1 Transcriptional silencing elements and their binding factors |
| 02/16/2000 | EP0979291A1 Methods of production of an amidated peptide through the use of a fusion protein |
| 02/16/2000 | EP0979290A2 Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors |
| 02/16/2000 | EP0979288A2 Diagnosis and treatment of phosphatase- or kinase-related disorders |
| 02/16/2000 | EP0979285A1 Methods to detect granulocytic ehrlichiosis |
| 02/16/2000 | EP0979284A2 Methods and reagents for vaccination which generate a cd8 t cell immune response |
| 02/16/2000 | EP0979283A2 Genes controlling floral development and apical dominance in plants |
| 02/16/2000 | EP0979282A1 Rat st38.2 chemokine |
| 02/16/2000 | EP0979280A1 Polynucleotides encoding a cd53-like transmembrane protein |
| 02/16/2000 | EP0979279A2 Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging |
| 02/16/2000 | EP0979278A1 Methods for detecting and reversing resistance to macrocyclic lactone compounds |
| 02/16/2000 | EP0979277A1 Novel human tumour suppressor gene |
| 02/16/2000 | EP0979276A1 Complement receptor type 1 (cr1)-like sequences |
| 02/16/2000 | EP0979275A1 Novel human mago nashi protein |
| 02/16/2000 | EP0979274A2 Human p24 vesicle proteins |
| 02/16/2000 | EP0979272A1 Strl33, a human fusion accessory factor associated with hiv infection |
| 02/16/2000 | EP0979271A1 Vascular adhesion protein-1 having amine oxidase activity |
| 02/16/2000 | EP0979245A1 Oligopeptidic inhibitors of elastases and methods of preparation thereof |
| 02/16/2000 | EP0979243A2 Activation of peptides |
| 02/16/2000 | EP0979239A1 Prevention and treatment of hepatocellular cancer |
| 02/16/2000 | EP0979238A1 Method of alleviating neuropathic pain |
| 02/16/2000 | EP0979237A1 Method for removing viruses from protein solution by nanofiltration |
| 02/16/2000 | EP0979235A1 Isolated nucleic acid molecule coding for tumor rejection antigen precursors mage-c1 and mage-c2 and uses thereof |
| 02/16/2000 | EP0979234A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders |
| 02/16/2000 | EP0979102A1 Polyalkylene oxide-modified single chain polypeptides |
| 02/16/2000 | EP0979101A1 Recombinant canine adenovirus (cav) containing exogenous dna |
| 02/16/2000 | EP0979094A2 Agent for enhancing the heart force |
| 02/16/2000 | EP0832131B1 Separating unmodified hemoglobin from cross-linked hemoglobin |
| 02/16/2000 | EP0561885B1 Subunit papillomavirus vaccine |
| 02/16/2000 | CN1244896A Non-M, non-O, HIV-1 strains, fragments and applications |
| 02/16/2000 | CN1244895A Carrot anti-freeze polypeptides |
| 02/16/2000 | CN1244872A Glucagon-like peptide-2 analogs |
| 02/16/2000 | CN1244871A H. pylori antigens |
| 02/16/2000 | CN1244870A Tissue specific expression of retinoblastoma protein |
| 02/16/2000 | CN1244804A Peptide immunotherapeutic agent |
| 02/16/2000 | CN1244803A Soluble CTLA4 mutant molecules and uses thereof |
| 02/16/2000 | CN1244769A Antimicrobial proteins |
| 02/16/2000 | CN1244585A Method for leading-in petunia transcription factor Pet SPL 2 gene to shorten inflorescence internode |
| 02/16/2000 | CN1244584A Chemotarix factor with immunocyte chemotaxis and hemopoinesis stimulating activity |
| 02/16/2000 | CN1244583A Preparation and application of native swine vescular disease virus strain and its variant strain |
| 02/16/2000 | CN1244536A Angiogenesis inhibiting factor 1 and its derivative and application |
| 02/16/2000 | CN1049454C Method for producing transgenic corn plants |
| 02/16/2000 | CN1049356C Protein-containing aqueous solutions |